Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Stress Biomarkers Among Patients Undergoing Treatment for Excited Delirium and Severe Pain in the Emergency Department
Stress Biomarkers Among Patients Undergoing Treatment for Excited Delirium and Severe Pain in the Emergency Department
Status: Enrolling
Updated:  12/22/2015
Hennepin County Medical Center
mi
from
Minneapolis, MN
Stress Biomarkers Among Patients Undergoing Treatment for Excited Delirium and Severe Pain in the Emergency Department
Stress Biomarkers Among Patients Undergoing Treatment for Excited Delirium and Severe Pain in the Emergency Department
Status: Enrolling
Updated: 12/22/2015
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
A 4-Week Randomized, Double-Blind, Placebo-Controlled, Phase 2a Safety and PK Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
Status: Enrolling
Updated:  12/22/2015
Massachusetts General Hospital
mi
from
Boston, MA
A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
A 4-Week Randomized, Double-Blind, Placebo-Controlled, Phase 2a Safety and PK Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
Status: Enrolling
Updated: 12/22/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
A 4-Week Randomized, Double-Blind, Placebo-Controlled, Phase 2a Safety and PK Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
Status: Enrolling
Updated:  12/22/2015
The University of California Irvine
mi
from
Orange, CA
A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
A 4-Week Randomized, Double-Blind, Placebo-Controlled, Phase 2a Safety and PK Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
Status: Enrolling
Updated: 12/22/2015
The University of California Irvine
mi
from
Orange, CA
Click here to add this to my saved trials
A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
A 4-Week Randomized, Double-Blind, Placebo-Controlled, Phase 2a Safety and PK Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
Status: Enrolling
Updated:  12/22/2015
The University of California, San Diego
mi
from
La Jolla, CA
A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
A 4-Week Randomized, Double-Blind, Placebo-Controlled, Phase 2a Safety and PK Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
Status: Enrolling
Updated: 12/22/2015
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Effects of Adjunctive Lacosamide on Mood States and Quality of Life (QOL) in Patients With Epilepsy
Effects of Adjunctive Lacosamide on Mood States and Quality of Life (QOL) in Patients With Epilepsy
Status: Enrolling
Updated:  12/23/2015
SUNY Downstate Medical Center
mi
from
Brooklyn, NY
Effects of Adjunctive Lacosamide on Mood States and Quality of Life (QOL) in Patients With Epilepsy
Effects of Adjunctive Lacosamide on Mood States and Quality of Life (QOL) in Patients With Epilepsy
Status: Enrolling
Updated: 12/23/2015
SUNY Downstate Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Cognitive Training Trial
Efficacy of a Cognitive Training Intervention for Children With ADHD
Status: Enrolling
Updated:  12/28/2015
Center for ADHD, Cincinnati Childrens Hospital Medical Center
mi
from
Cincinnati, OH
Cognitive Training Trial
Efficacy of a Cognitive Training Intervention for Children With ADHD
Status: Enrolling
Updated: 12/28/2015
Center for ADHD, Cincinnati Childrens Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Phoenix, AZ
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Denver, CO
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Denver, CO
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Lake Barrington, IL
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Lake Barrington, IL
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Indianapolis, IN
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Lexington, KY
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Lexington, KY
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Bingham Farms, MI
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Albuquerque, NM
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Albany, NY
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Albany, NY
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Asheville, NC
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Asheville, NC
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Akron, OH
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Akron, OH
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Franklin, TN
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Franklin, TN
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Vienna, VA
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Vienna, VA
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Seattle, WA
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Tucson, AZ
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Berkeley, CA
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Berkeley, CA
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
San Diego, CA
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Port Charlotte, FL
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Sarasota, FL
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Sarasota, FL
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
St. Petersburg, FL
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Tampa, FL
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Lenexa, KA
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Lenexa, KA
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Detroit, MI
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Toms River, NJ
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Toms River, NJ
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Patchogue, NY
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Patchogue, NY
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Plainview, NY
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Plainview, NY
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Nashville, TN
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
San Antonio, TX
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Tacoma, WA
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
Assessment and Referral Versus Exercise in Primary Prevention of Falls: PA Healthy Steps Program
Assessment and Referral Versus Exercise in Primary Prevention of Falls: PA Healthy Steps Program
Status: Enrolling
Updated:  12/29/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Assessment and Referral Versus Exercise in Primary Prevention of Falls: PA Healthy Steps Program
Assessment and Referral Versus Exercise in Primary Prevention of Falls: PA Healthy Steps Program
Status: Enrolling
Updated: 12/29/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Continuous Neurophysiological Monitoring Detection of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Subjects
Real Time Continuous Neurophysiological Monitoring for Early Detection of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Subjects
Status: Enrolling
Updated:  12/30/2015
SUNY Upstate Medical University
mi
from
Syracuse, NY
Continuous Neurophysiological Monitoring Detection of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Subjects
Real Time Continuous Neurophysiological Monitoring for Early Detection of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Subjects
Status: Enrolling
Updated: 12/30/2015
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates
Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates
Status: Enrolling
Updated:  12/30/2015
Los Angeles Biomedical Research Institute atHarbor-UCLA Medical Center
mi
from
Torrance, CA
Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates
Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates
Status: Enrolling
Updated: 12/30/2015
Los Angeles Biomedical Research Institute atHarbor-UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
Mobilaser Study to Help With People Who Are Having Problems With Their Gait
Increasing Mobility in Parkinsonian Patients With Freezing of Gait and Gait Hypokinesia With an Adjustable, Attachable Laser (Mobilaser)
Status: Enrolling
Updated:  12/30/2015
Mayo Clinic Florida
mi
from
Jacksonville, FL
Mobilaser Study to Help With People Who Are Having Problems With Their Gait
Increasing Mobility in Parkinsonian Patients With Freezing of Gait and Gait Hypokinesia With an Adjustable, Attachable Laser (Mobilaser)
Status: Enrolling
Updated: 12/30/2015
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Sildenafil for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury.
Sildenafil for the Treatment of Cerebrovascular Dysfunction During the Chronic Stage After Traumatic Brain Injury.
Status: Enrolling
Updated:  12/30/2015
National Institute of Health
mi
from
Bethesda, MD
Sildenafil for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury.
Sildenafil for the Treatment of Cerebrovascular Dysfunction During the Chronic Stage After Traumatic Brain Injury.
Status: Enrolling
Updated: 12/30/2015
National Institute of Health
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
Downey, CA
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
Downey, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
Gilroy, CA
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
Gilroy, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
Pasadena, CA
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
Pasadena, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
San Jose, CA
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
San Jose, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
Englewood, CO
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
Englewood, CO
Click here to add this to my saved trials
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
Miami, FL
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
Atlanta, GA
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
Chicago, IL
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
Kansas City, KA
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
Detroit, MI
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials